Amyloid in the heart: an under-recognized threat at the interface of cardiology, haematology, and pathology

Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis

(2016) Julien Ternacle et al.   JACC-Cardiovascular Imaging

Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis

(2016) Sabha Bhatti et al.   European Heart Journal-Cardiovascular Imaging

Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study

(2016) Dania Mohty et al.   European Heart Journal-Cardiovascular Imaging

A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis

(2015) G. Palladini et al.   BLOOD

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac AmyloidosisCLINICAL PERSPECTIVE

(2015) Marianna Fontana et al.   CIRCULATION

The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics

(2015) Stefan Aschauer et al.   EUROPEAN JOURNAL OF HEART FAILURE